Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors

Fifteen novel non-peptide compounds were developed. Compound 3e exhibited the inhibitory activities of CT-L and solid tumor cell in the nanomolar range, and showed more improved metabolic stability than bortezomib.298